Dr Reddys Labs unveils Versavo in UK for several types of cancers Ruchika Sharma20 March 2024 2:30 PM ISTHyderabad: Dr Reddy's Laboratories Ltd., a global pharmaceutical company, has announced the launch of Versavo (bevacizumab) in the United Kingdom...
EMA validates marketing authorisation applications for AstraZeneca, Daiichi Sankyo datopotamab deruxtecan in lung, breast cancer Ruchika Sharma6 March 2024 3:25 PM ISTCambridge: The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for AstraZeneca and Daiichi Sankyo’s...
USFDA nod to JnJ for Rybrevant, Chemotherapy combo for lung cancer treatment Anshika Mishra4 March 2024 5:09 PM ISTJohnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Health Bulletin 04/ March/ 2024 Anshika Mishra4 March 2024 4:44 PM ISTHere the top health news for the day :Lady hardinge medical college to introduce new DNB and FNB courses soon Bringing good news to the postgraduate...
Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment Ruchika Sharma2 March 2024 2:33 PM ISTRaritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Bayer gets USFDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations Ruchika Sharma29 Feb 2024 1:30 PM ISTBAY 2927088 was derived from Bayer's long-standing strategic research alliance with the Broad Institute of MIT and Harvard in Cambridge, MA, USA.
AstraZeneca-Daiichi Sankyo application for Datopotamab deruxtecan accepted in US for patients with previously treated advanced nonsquamous non-small cell lung cancer Ruchika Sharma19 Feb 2024 4:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US...
AstraZeneca Tagrisso with chemotherapy approved in US for EGFR-mutated advanced lung cancer Ruchika Sharma17 Feb 2024 12:00 PM ISTTagrisso (osimertinib) is a third-generation, irreversible EGFR-TKI with proven clinical activity in NSCLC, including against CNS metastases.
Sustained smoking cessation may significantly lower risk of cancer after ten years since quitting: JAMA Medha Baranwal9 Feb 2024 1:00 AM ISTSouth Korea: A study of more than 2 million Korean adults revealed that sustained smoking cessation is associated with a significantly reduced cancer...
Global cancer cases expected to rise 77 percent by 2050, says WHO report Roshni Dhar6 Feb 2024 5:50 PM ISTA new report from the World Health Organization (WHO) warns of a significant rise in global cancer cases by 2050. According to the WHO's International...
Health Bulletin 06/February/2024 Roshni Dhar6 Feb 2024 5:04 PM ISTHere are the top health news for the day:NBEMS cuts NEET PG 2024 registration fees by Rs 750Offering major relief to the National...
Exposure to even moderate levels of radon linked to increased risk of stroke Dr. Kamal Kant Kohli5 Feb 2024 10:30 PM ISTRadon is the second leading cause of lung cancer. Now a new study has found exposure to this invisible, odorless gas is also linked to an increased...
